“Synthesis and Characterization of YYGSR-NH2 As a Chemical Starting Poin for Thyroid Theranostic Radiopharmaceutical Development”. 2026. JURNAL FARMASIMED (JFM) 9 (1): 830-41. https://doi.org/10.35451/jfm.v9i1.3856.